{"title":"Hepatitis C: diagnosis, treatment and harm‐reduction strategies","authors":"G. Parsons","doi":"10.1002/psb.2001","DOIUrl":null,"url":null,"abstract":"The introduction of new and effective direct‐acting antivirals has revolutionised the treatment of hepatitis C over the last decade. Part 2 of this two‐part series on the management of hepatitis C provides an overview of these new treatments, as well as discussing hepatitis C diagnosis and harm‐reduction strategies.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/psb.2001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The introduction of new and effective direct‐acting antivirals has revolutionised the treatment of hepatitis C over the last decade. Part 2 of this two‐part series on the management of hepatitis C provides an overview of these new treatments, as well as discussing hepatitis C diagnosis and harm‐reduction strategies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
